Logo-jcvtr

J Cardiovasc Thorac Res. 2019;11(4): 254-263. doi: 10.15171/jcvtr.2019.43
PMID: 31824606        PMCID: PMC6891044

Review Article

Risk of type 2 diabetes in metabolically healthy people in different categories of body mass index: an updated network meta-analysis of prospective cohort studies

Somayeh Tajik 1, Atieh Mirzababaei 1,2 * ORCID, Ehsan Ghaedi 3, Hamed Kord-Varkaneh 4 * , Khadijeh Mirzaei 1

Cited by CrossRef: 11

1- Llamosas-Falcón L, Rehm J, Bright S, Buckley C, Carr T, Kilian C, Lasserre A, Lemp J, Zhu Y, Probst C. The Relationship Between Alcohol Consumption, BMI, and Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis. 2023;46(11):2076 [Crossref]
2- Wei Y, Wang R, Wang J, Han X, Wang F, Zhang Z, Xu Y, Zhang X, Guo H, Yang H, Li X, He M. Transitions in Metabolic Health Status and Obesity Over Time and Risk of Diabetes: The Dongfeng–Tongji Cohort Study. 2023;108(8):2024 [Crossref]
3- Zhang J, Xu Q, Lai F, Chen N, Lin M, Liu Y, Zhang W, Liu C, Wang S, Li Z. Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults. BMJ Open Diab Res Care. 2021;9(1):e002362 [Crossref]
4- Chaves S, Silva Araújo D, Guilherme L, Agostinho P. Diagnosis, physiological mechanisms, risk factors, treatment and prevention of obesity: A brief commentary. Obesity Medicine. 2024;52:100572 [Crossref]
5- Alasvand Zarasvand S, Ogawa S, Nestor B, Bridges W, Haley-Zitlin V. Effects of Herbal Tea (Non–Camellia sinensis) on Glucose Homeostasis and Serum Lipids in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. 2025;83(3):e1128 [Crossref]
6- Wang X, Wu Y, Wang Y, Zhou J, Liu T. Relationship between metabolically healthy overweight/obesity and risk of type 2 diabetes in different ethnicity: a prospective cohort study in southwest China. BMC Public Health. 2024;24(1) [Crossref]
7- Dragano N, Fernø J, Diéguez C, López M, Milbank E. Recent Updates on Obesity Treatments: Available Drugs and Future Directions. Neuroscience. 2020;437:215 [Crossref]
8- Bashir M. HIGH PREVALENCE OF OBESITY AND PHYSICAL INACTIVITY AMONG SELECTED WORKERS IN KANO STATE NIGERIA. FJS. 2025;9(7):345 [Crossref]
9- Lin B, Lin T, Lin C, Liao L, Chang T, Lu B, Chen K. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease. 2021;84(6):606 [Crossref]
10- Zhang Z, Peng W, Zhang F, Lu P, Huang L, Sun S. Effects of a dynamically adjusted exercise prescription in adults with overweight and obesity. Science & Sports. 2026; [Crossref]
11- Dragano N, Fernø J, Diéguez C, López M, Milbank E. Reprint of: Recent Updates on Obesity Treatments: Available Drugs and Future Directions. Neuroscience. 2020;447:191 [Crossref]
12- Hoddy K, Axelrod C, Mey J, Hari A, Beyl R, Blair J, Dantas W, Kirwan J. Insulin resistance persists despite a metabolically healthy obesity phenotype. Obesity. 2022;30(1):39 [Crossref]
13- Jo J, Ha N, Ji Y, Do A, Seo J, Oh B, Choi S, Choe E, Lee W, Son J, Won S. Genetic determinants of obesity in Korean populations: exploring genome-wide associations and polygenic risk scores. 2024;25(5) [Crossref]
14- Liu H, Zhang H, Zhao B, Prabahar K, Kord-Varkaneh H, Liu X. Effects of carnitine supplementation on glycemic markers in women with overweight and obesity: A systematic review and meta-analysis of randomized controlled trials. Diabetes Research and Clinical Practice. 2025;230:112981 [Crossref]
15- Ottosson F, Smith E, Ericson U, Brunkwall L, Orho-Melander M, Di Somma S, Antonini P, Nilsson P, Fernandez C, Melander O. Metabolome-Defined Obesity and the Risk of Future Type 2 Diabetes and Mortality. 2022;45(5):1260 [Crossref]
16- Tsuchiya K, Tsutsumi T. Beyond the BMI Paradox: Unraveling the Cellular and Molecular Determinants of Metabolic Health in Obesity. Biomolecules. 2025;15(9):1278 [Crossref]
17- Yan L, Zhang X, Xu F, Fan Y, Ge B, Guo H, Li Z. Four-microRNA signature for detection of type 2 diabetes. WJCC. 2020;8(10):1923 [Crossref]
18- Wang M, Ou Y, Yuan X, Zhu X, Niu B, Kang Z, Zhang B, Ahmed A, Xing G, Su H. Heterogeneously elevated branched-chain/aromatic amino acids among new-onset type-2 diabetes mellitus patients are potentially skewed diabetes predictors. World J Diabetes. 2024;15(1):53 [Crossref]
19- Zhu X, Hu J, Guo H, Ji D, Yuan D, Li M, Yan T, Xue C, Ma H, Zhou X, Liu Y, Li Y, Sun K, Liu Y, Sun Z, Wang B. Effect of Metabolic Health and Obesity Phenotype on Risk of Diabetes Mellitus: A Population-Based Longitudinal Study. DMSO. 2021;Volume 14:3485 [Crossref]
20- Cefalo C, Riccio A, Succurro E, Marini M, Fiorentino T, Rubino M, Perticone M, Sciacqua A, Andreozzi F, Sesti G. Frequency of prediabetes in individuals with increased adiposity and metabolically healthy or unhealthy phenotypes. Diabetes Obesity Metabolism. 2024;26(8):3191 [Crossref]
21- Mir F, Abdesselem H, Cyprian F, Iskandarani A, Doudin A, Shraim M, Alkhalaf B, Alkasem M, Abdalhakam I, Bensmail I, Al Halabi H, Taheri S, Abou-Samra A. Metabolically Healthy Obesity Is Characterized by a Distinct Proteome Signature. IJMS. 2025;26(5):2262 [Crossref]
22- Schulze M, Stefan N. Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications. Nat Rev Endocrinol. 2024;20(11):633 [Crossref]
23- Ahmad M, Zawatia A. Current prospects of metabolically healthy obesity. Obesity Medicine. 2021;25:100361 [Crossref]
24- de Medeiros W, Gomes A, Aguiar A, de Queiroz J, Bezerra I, da Silva-Maia J, Piuvezam G, Morais A. Anti-Obesity Therapeutic Targets Studied In Silico and In Vivo: A Systematic Review. IJMS. 2024;25(9):4699 [Crossref]